All of Us Research Program

Post author:Bree Clare
Post published:August 1, 2025
Post category:Rare Disease

Acknowledgement: Patient Worthy is honored to be a media partner of the National Organization for Rare Disorders (NORD). The mission of NORD is to improve the health and well-being of…

source: pixabay.com

Study: AV-101 for the Treatment of Dyskinesia in those with Parkinson’s Disease

Post author:Kendall Mason
Post published:February 11, 2020
Post category:Parkinson's Disease

VistaGen Therapeutics has recently been cleared by the FDA to begin the second phase of their study of AV-101, which is intended for the treatment of dyskinesia in those affected…

You Need to Participate in the All of Us Research Program of the Precision Medicine Initiative

Post author:Patient Worthy Contributor
Post published:February 27, 2017
Post category:Rare Disease

The All of Us Research Program (The Program) at NIH is AWESOME. Here's what I learned at Rare Disease Day at NIH (#RDDNIH) and what you should know too, so…

Study: AV-101 for the Treatment of Dyskinesia in those with Parkinson’s Disease

You Need to Participate in the All of Us Research Program of the Precision Medicine Initiative

Let’s Work Together!

Keep Up to Date

Learn More